Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRTX vs MRNA✓SelectedUSD · MRNAVRTX vs MRNA performance historyLatest closeAs of-1.08%11/20
Stock and ETF performance explorer

VRTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+199.1%
MRNA return
+786.4%
Excess return
-587.3%
Maximum drawdown
-41.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-2.2%+1.1%-1.0%
7D-4.4%-12.7%+8.3%-3.6%
30D-1.8%-20.7%+18.9%-0.7%
3M-4.7%+46.3%-50.9%-7.3%
6M+19.6%+305.2%-285.6%+3.9%
YTD+13.6%+561.2%-547.6%-5.4%
1Y+22.0%+772.1%-750.1%-0.7%
3Y+44.3%+147.0%-102.6%+24.7%
5Y+181.6%-26.1%+207.7%+154.6%
All+199.1%+786.4%-587.3%+116.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling